Cartilage and bone repair and regeneration using postpartum-derived cells
a postpartum derived cell and cartilage technology, applied in the field of mammalian cell biology and cell culture, can solve the problems of fibrocartilage formation at the site of full thickness defect, fibrocartilage lacks the biomechanical properties of articular cartilage, and failure to persist in the joint on a long-term basis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
example 1
Derivation of Cells from Postpartum Tissues
[0293] The objective of this study was to derive populations of cells from placental and umbilical cord tissues. Postpartum umbilical cord and placenta were obtained upon birth of either a full term or pre-term pregnancy. Cells were harvested from 5 separate donors of umbilical cord and placental tissue. Different methods of cell isolation were tested for their ability to yield cells with: 1) the potential to differentiate into cells with different phenotypes, or 2) the potential to provide critical trophic factors useful for other cells and tissues.
[0294] Methods & Materials
[0295] Umbilical cord cell derivation. Umbilical cords were obtained from National Disease Research Interchange (NDRI, Philadelphia, Pa.). The tissues were obtained following normal deliveries. The cell isolation protocol was performed aseptically in a laminar flow hood. To remove blood and debris, the umbilical cord was washed in phosphate buffered saline (PBS; Invi...
example 2
Evaluation of Growth Media for Postpartum-Derived Cells
[0321] Several cell culture media were evaluated for their ability to support the growth of placenta-derived cells. The growth of placenta-derived cells in normal (20%) and low (5%) oxygen was assessed after 3 days using the MTS calorimetric assay.
[0322] Methods & Materials
[0323] Placenta-derived cells at passage 8 (P8) were seeded at 1×103 cells / well in 96 well plates in Growth medium (DMEM-low glucose (Gibco, Carlsbad Calif.), 15% (v / v) fetal bovine serum (Cat. #SH30070.03; Hyclone, Logan, Utah), 0.001% (v / v) betamercaptoethanol (Sigma, St. Louis, Mo.), 50 Units / milliliter penicillin, 50 micrograms / milliliter streptomycin (Gibco)). After 8 hours, the medium was changed as described in Table 2-1, and cells were incubated in normal (20%, v / v) or low (5%, v / v) oxygen at 37° C., 5% CO2 for 48 hours. MTS was added to the culture medium (CELLTITER 96 AQueous One Solution Cell Proliferation Assay, Promega, Madison, Wis.) for 3 hou...
example 3
Growth of Postpartum-Derived Cells in Medium Containing D-Valine
[0332] It has been reported that medium containing D-valine instead of the normal L-valine isoform can be used to selectively inhibit the growth of fibroblast-like cells in culture (Hongpaisan, 2000; Sordillo et al., 1988). The growth of postpartum-derived cells in medium containing D-valine in the absence of L-valine was evaluated.
[0333] Methods & Materials
[0334] Placenta-derived cells (P3), fibroblasts (P9), and umbilical cord-derived cells (P5) were seeded at 5×103 cells / cm2 in gelatin-coated T75 flasks (Corning, Corning, N.Y.). After 24 hours the medium was removed and the cells were washed with phosphate buffered saline (PBS) (Gibco, Carlsbad, Calif.) to remove residual medium. The medium was replaced with a Modified Growth medium (DMEM with D-valine (special order Gibco), 15% (v / v) dialyzed fetal bovine serum (Hyclone, Logan, Utah), 0.001% (v / v) betamercaptoethanol (Sigma), 50 Units / milliliter penicillin, 50 mi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com